Makale detayı · 2018 · article
Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS
Dergi
Clinical Rheumatology
ISSN0770-3198
YÖKSİS
OpenAlex
Üst %10
Yıl2018
Atıf63OpenAlex
Yüzdelik%96,1
FWCI5,191,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q3
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıClinical rheumatology
- Katalog eşleşmesi (ISSN)Clinical Rheumatology
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
63atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 26 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2019 Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?Atıf 25 · OpenAlex
- 2019 Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?Atıf 25 · OpenAlex
- 2019 Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?Atıf 25 · OpenAlex
- 2021 The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitisAtıf 11 · OpenAlex
- 2021 The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitisAtıf 11 · OpenAlex
- 2021 The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitisAtıf 11 · OpenAlex
- 2023 Evaluation of pro‐atherogenic lipid profile and high atherohenic indexes in patients with Behçet's disease: A case–control studyAtıf 8 · OpenAlex
- 2023 Syndecan 1 may slow the progression of subclinical atherosclerosis in patients with ankylosing spondylitisAtıf 8 · OpenAlex
- 2023 Syndecan 1 may slow the progression of subclinical atherosclerosis in patients with ankylosing spondylitisAtıf 8 · OpenAlex
- 2022 Syndecan 1 may slow the progression of subclinical atherosclerosis in patients with ankylosing spondylitisAtıf 8 · OpenAlex